Evidence map›Paper›PMID 37634737›Full record

ArticleJournal of the American Academy of Dermatology2024

Perifollicular linear projections: A dermatoscopic criterion for the diagnosis of lentigo maligna on the face.

Cristian Navarrete-Dechent, Natalia Jaimes, Stephen W Dusza, Konstantinos Liopyris, Michael A Marchetti, Miguel Cordova, Margaret Oliviero, Miguel A Villaseca, Melissa Pulitzer, Klaus J Busam and 5 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Academy of Dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. International Dermoscopy Society consensus recommendations for the management of lentigo maligna.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 3 countries.

Cristian Navarrete-DechentDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Dermatology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile; Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile. Electronic address: ctnavarr@gmail.com.
Natalia JaimesDr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.
Stephen W DuszaDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Konstantinos LiopyrisDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Dermatology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Michael A MarchettiDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Miguel CordovaDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Margaret OlivieroSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.
Miguel A VillasecaMelanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile; Department of Pathology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Melissa PulitzerDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Klaus J BusamDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Anthony M RossiDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Harold S RabinovitzSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.
Kishwer S NehalDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Alon ScopeDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; The Kittner Skin Cancer Screening & Research Institute, Sheba Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ashfaq A MarghoobDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: marghooa@mskcc.org.
Memorial Sloan Kettering Cancer Center · USUniversity of Miami · USPontificia Universidad Católica de Chile · CL

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundLentigo maligna (LM) can mimic benign, flat, pigmented lesions and can be challenging to diagnose.

objectiveTo describe a new dermatoscopic feature termed "perifollicular linear projections (PLP)" as a diagnostic criterion for LM on the face.

methodsRetrospective study on reflectance confocal microscopy and dermatoscopy images of flat facial pigmented lesions originating from 2 databases. PLP were defined as short, linear, pigmented projections emanating from hair follicles. Dermatoscopy readers were blinded to the final histopathologic diagnosis.

resultsFrom 83 consecutive LMs, 21/83 (25.3%) displayed "bulging of hair follicles" on reflectance confocal microscopy and 18 of these 21 (85.7%), displayed PLP on dermatoscopy. From a database of 2873 consecutively imaged and biopsied lesions, 252 flat-pigmented facial lesions were included. PLP was seen in 47/76 melanomas (61.8%), compared with 7/176 lesions (3.9%) with other diagnosis (P < .001). The sensitivity was 61.8% (95% CI, 49.9%-72.7%), specificity 96.0% (95% CI, 92.9%-98.4%). PLP was independently associated with LM diagnosis on multivariate analysis (OR 26.1 [95% CI, 9.6%-71.0]). LIMITATIONS: Retrospective study.

conclusionPLP is a newly described dermatoscopic criterion that may add specificity and sensitivity to the early diagnosis of LM located on the face. We postulate that PLP constitutes an intermediary step in the LM progression model.

Indexed as

Hutchinson's Melanotic FreckleMelanomaSkin NeoplasmsDermoscopyDiagnosis, DifferentialHumansMicroscopy, ConfocalRetrospective Studiesbiopsydermatoscopyfacelentigo malignamelanomareflectance confocal microscopy

Identifiers

PMID37634737
PMCPMC11326498
OpenAlexW4386170502

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.